• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Diabetes Treatments, The

$995.00 – $1,990.00

Clear
SKU: KLI2809047 Categories: Drug Delivery Market Reports, Pharmaceuticals Market Research Pages: 260
  • Description
  • Table of Contents
  • Latest reports

Description

This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments. The diabetes market is one of the fastest growing markets within the pharmaceutical sector, and is one of the few pharmaceutical sectors that are likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an aging worldwide population. The total market for diabetes treatments is divided into two major segments:

 

  • Insulin Markets in US, Europe, Japan, ROW
  • Oral Hypoglycemics in US, Europe, Japan, ROW

 

For each of these market segments the report provides market share and regional breakout (US, Europe, Asia, ROW). The report also discusses treatment for diabetes complications and natural and herbal treatments.

The report’s geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Trends covered in the report include:

 

  • New Products and the Development Pipeline (Afrezza,
    Bydureon, Syncria, AVE0010, Balaglitazone, Metgluna
    Otelixizumab and others)
  • Transplantation Research Efforts
  • Β-Cell Transplantation Research
  • Potential New Drug for Type 2 Diabetes
  • Insulin Pills
  • Three-month Insulin Shot
  • Outsourcing of Diabetes Projects
  • Reclassification of Cause of Death

Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets.

A market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included, including profiles of the following:

 

  • Amylin Pharmaceuticals
  • AstraZeneca
  • GlaxoSmithKline
  • Eli Lilly & Co.
  • Merck
  • Metabolex, Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi-Aventis Group
  • Takeda Pharmaceutical Company Limited

 

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information.

For the purpose of this study, Kalorama Information conducted interviews with more than 25 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2008, with forecast data provided for 2010 through 2015. Compound annual growth rates (CAGRs) are provided for 2008-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2015 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting Market
  • Leading Competitors

CHAPTER TWO: INTRODUCTION

  • Background
  • Therapeutic Practices
  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • United Kingdom
  • United States
  • China
  • India

CHAPTER THREE: CURRENT THERAPEUTICS FOR DIABETES

  • Insulin
    • Regular Insulin
    • Long-Acting and Basal Insulin
    • Rapidly Acting Insulin
    • Combinations
    • Insulin Pumps
    • Insulin Pens
    • Inhaled Insulin
    • Other Treatments
  • Oral Hypoglycemics
    • SulfonylureasBiguanides
    • á-Glucosidase Inhibitors
    • Thiazolidinediones
    • Meglitinides
    • D-Phenylalanine Derivatives
    • GLP1 Agonists
    • DPP-IV Inhibitor
  • Current Therapeutics for Diabetic Complications
    • Antihypertensive Therapy
    • ACE Inhibitors
    • á/â(Alpha/Beta)-Blockers
    • Calcium Channel Blockers
    • Diuretics
    • Angiotensin II Receptor Antagonists
  • Dyslipidemia Therapy
  • HMG-CoA Reductase Inhibitors–Statins
  • Bile Acid Sequestrants
  • Fibric Acid Derivatives
  • Niacin
  • Cholesterol Absorption Inhibitors
  • Atherosclerosis Therapy
  • Arrhythmia Therapy
  • Peripheral Vascular Disease Therapy

CHAPTER THREE: TOTAL MARKET REVENUES, FORECAST AND COMPETITIVE ANALYSIS

  • Total Worldwide Diabetes Market Analysis by Geographic Segment
  • Total Worldwide Diabetes Market Competitive Analysis
  • Total Worldwide Diabetes Market by Segment
  • Insulin
  • Oral Hypoglycemics

CHAPTER FOUR: KEY ISSUES, TRENDS AND DEVELOPMENTS

  • New Products and the Development Pipeline
    • Afrezza
    • Bydureon
    • Syncria
    • AVE0010 Once Daily and Twice Daily
    • Balaglitazone
    • Dapagliflozin and Dapagliflozin/Meformin Fixed Dose Combination
    • Degludec and Degludec Plus
    • Daimyd Vaccine
    • Dutogliptin
    • Glinsuma, Glufast, Metgluna
    • MK 0431C
    • Ondero
    • Oral-lyn
    • Otelixizumab
    • Taspoglutide
  • Transplantation Research Efforts
    • Â-Cell Transplantation Research
  • Potential New Drug for Type 2 Diabetes
  • Insulin Pills
  • Three-month Insulin Shot
  • Outsourcing of Diabetes Projects
  • Reclassification of Cause of Death

CHAPTER FIVE: NUTRITIONAL SUPPLEMENT AND HERBAL APPROACHES TO THE TREATMENT OF DIABETES

  • Background
  • Nutritional Supplements
    • Ascorbic Acid (Vitamin C)
    • Biotin
    • Chromium
    • Copper
    • Magnesium
    • Niacin and Niacinamide
    • Potassium
    • Selenium
    • Thiamine
    • Vanadium
    • Vitamin B6 (Pyridoxine)
    • Vitamin B12
    • Vitamin E
    • Zinc
  • Nutritional Treatment of Diabetic Neuropathy
    • Herbal Treatment of Diabetes
      • Aloe (Various)
      • Arctium lappa (Burdock Root)
      • Allium cepa (Onion)
      • Grifola frondosa (Maitake Mushroom)
      • Mulberry
      • Panax ginseng (Korean ginseng)
    • Ayurvedic Medicine and Herbs
      • Gymnema sylvestre (Asclepias germinata)
      • Momordica charantia (Bitter Gourd)
      • Trigonella foenum graecum (Fenugreek)
    • Other Herbs with Significant Anti-Diabetic Effects
    • Traditional Chinese Medicine

CHAPTER SIX: CONCLUSIONS AND STRATEGIC IMPLICATIONS

  • First Conclusion
    • Implications:
  • Second Conclusion
    • Implications:
  • Third Conclusion
    • Implications:
  • Fourth Conclusion
    • Implications:
  • Fifth Conclusion
    • Implications:
  • Sixth Conclusion
    • Implications:
  • Seventh Conclusion
    • Implications:
  • Eighth Conclusion
    • Implications:
  • Ninth Conclusion
    • Implications:
  • Tenth Conclusion
    • Implications:
  • Eleventh Conclusion
    • Implications:
  • Twelfth Conclusion
    • Implications:
  • Thirteenth Conclusion
    • Implications:
  • Fourteenth Conclusion
    • Implications:
  • Fifteenth Conclusion
    • Implications:

CHAPTER SEVEN: LEADING MANUFACTURERS

  • Overview
  • Amylin Pharmaceuticals
  • AstraZeneca
  • GlaxoSmithKline
  • Eli Lilly & Co.
  • Merck
  • Metabolex, Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi-Aventis Group
  • Takeda Pharmaceutical Company Limited

APPENDIX A: GLOSSARY

APPENDIX B: COMPANY DIRECTORY

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00
  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00
  • Placeholder image

    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    $1,496.00 – $2,992.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th...Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other...
Scroll to top